Revenue (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Summary of Revenue

For the three months ended March 31, 2025 and 2024, revenue comprised the following:

	Three Months Ended March 31,
(in thousands)	2025	2024
Prescription transactions revenue	$148,923	$145,395
Subscription revenue	21,017	22,601
Pharma manufacturer solutions revenue	28,648	24,509
Other revenue	4,382	5,375
Total revenue	$202,970	$197,880